ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,551.64
      1.08%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      10/10/20177:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/10/20174:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/06/20175:20PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/06/20174:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/28/20174:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/22/20175:44PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/21/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/13/20174:54PMGlobeNewswire Inc.Adamas to Host Investor and Analyst Meeting on September 18, 2017NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/11/20175:05PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/11/20175:00PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/07/20174:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      09/07/20178:30AMGlobeNewswire Inc.Adamas Announces Topline Phase 1b Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyNASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/24/20174:16PMGlobeNewswire Inc.Adamas Announces FDA Approval of GOCOVRI™ as First and Only Medication for the Treatment of Dyskinesia in Parkinson’s Dis...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/08/20174:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/08/20174:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/08/20174:01PMGlobeNewswire Inc.Adamas Reports Recent Achievements and Second Quarter 2017 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      08/01/20172:34PMGlobeNewswire Inc.Adamas to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8, 2017NASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/10/20175:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/10/20174:33PMGlobeNewswire Inc.Adamas Reports Inducement Grant to New Chief Financial OfficerNASDAQ:ADMSAdamas Pharmaceuticals Inc
      07/06/20175:18PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/28/20179:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/28/20179:00AMGlobeNewswire Inc.Adamas Appoints New Chief Financial OfficerNASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/22/20175:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/12/20174:01PMGlobeNewswire Inc.Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA NeurologyNASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/08/20174:10PMGlobeNewswire Inc.Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study Showing Tolerability and Durability out to 88 WeeksNASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20175:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20174:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20174:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20174:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20174:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS

      Your Recent History

      BIT
      UV8CMW
      UniCredit Bank
      BIT
      C00170
      Commerzbank
      Delayed Upgrade Clock